Table 3.
(a). Scientific Evidence that Activating Autophagy Is Promoting Liver Regeneration | |||||||
---|---|---|---|---|---|---|---|
Author Year |
Research Model | Pathway | Autophagy Modulation | Parameters Indicating | |||
Enhanced Autophagy | Enhanced Regeneration | Reduced Autophagy | Reduced Regeneration | ||||
Takeo [13] 2014 |
Mice | Not investigated | Atg5-KO | LC3-II: --- p62: +++ |
BrdU: --- | ||
Lin [26] 2015 |
C57BL/6 mice, Male | mTOR- independent |
Amiodarone | LC3-II: +++ p62: --- |
LBWR *: +++ Ki-67: +++ |
||
Atg7-KD | LC3-II: --- | LBWR *: --- Ki-67: --- |
|||||
Cheng [29] 2015 |
Liver progenitor cells | Not investigated | Overexpression of Beclin1 | LC3-II: +++ | PAS ×: +++ | ||
Beclin1-KD; Atg5-KD |
LC3-II: --- p62: +++ |
CCK-8: --- PAS: --- |
|||||
Liu [5] 2018 |
SD rats, Male, 3m, 22m; Primary rat hepatocytes |
Not investigated | Young plasma | LC3-II: +++ p62: --- |
Ki-67: +++ | ||
3-Methyladenine; Wortmannin |
LC3-II: --- | Ki-67: --- | |||||
Jia [28] 2019 |
SD rats, Male, 5w | Not investigated | 70% Portal Vein Ligation | LC3-II: +++ | Cyclin D1: +++ | ||
Guha [164] 2019 |
Mice; MEFs; HEK293T cells. |
IPMK-AMPK-ULK1; IPMK-AMPK-SIRT1 |
IPMK-KO | LC3-II: --- | Ki-67: --- Edu: --- |
||
(b). Scientific Evidence that Inducing Autophagy Is Inhibiting Liver Regeneration | |||||||
Author
Year |
Research Model | Pathway | Autophagy Modulation | Parameters Indicating | |||
Enhanced Autophagy | Reduced Regeneration | Reduced Autophagy | Enhanced Regeneration | ||||
Jiang [161] 2001 |
Harlan SD rats, Male | mTOR- dependent |
Rapamycin | Not investigated | LWRR **: --- | ||
Palme [159] 2008 |
Lewis rats, Male | mTOR- dependent |
Rapamycin | Not investigated | Ki-67: --- | ||
Fouraschen [160] 2013 |
C57BL/6 mice Male, 12–15w |
mTOR- dependent |
Rapamycin and Steroid dexamethasone |
LC3-II: +++ | BrdU: --- PCNA: --- LWRR **: --- |
||
Kawaguchi [27] 2013 | C57BL/6J mice, Male, 6–8w | mTOR- dependent |
Temsirolimus | Not investigated | LBWR *: --- PCNA: --- |
||
Shi [25] 2018 |
Balb/c mice, 6–8w | mTOR- dependent |
Rapamycin | LC3-II: +++ | LBWR *: --- PCNA: --- |
||
3-Methyladenine; | LC3-II: --- | LBWR *: +++ PCNA: +++ |
|||||
ASPP2-haploinsufficient | LC3-II: --- p62: +++ |
LBWR *: +++ PCNA: +++ |
+++: Increase; ---: Decrease. * LBWR: Liver to body weight ratio. ** LWRR: Liver weight recovery rate. × used for estimating the capacity of LPCs differentiated into hepatocytes.